1X10^6 C57BL/6 mouse splenocytes were surface co-stained with CoraLite® Plus 647 Anti-Mouse CD3 (17A2) and 0.5 ug Anti-Mouse CD103 (65047-1-Ig, Clone:2E7) and FITC anti-Armenian Hamster IgG Antibody at dilution 1:100, or 0.5 ug Armenian Hamster IgG isotype control and FITC anti-Armenian Hamster IgG Antibody at dilution 1:100. Cells were not fixed.
1X10^6 mouse splenocytes were surface co-stained with CoraLite® Plus 647 Anti-Mouse CD3 (17A2) and 1 ug CoraLite® Plus 405 Anti-Mouse CD103 (CL405-65047, Clone:2E7) or 1 ug Isotype Control. Cells were not fixed.
1X10^6 mouse splenocytes were surface co-stained with CoraLite® Plus 647 Anti-Mouse CD3 (17A2) and 0.5 ug CoraLite® Plus 488 Anti-Mouse CD103 (CL488-65047, Clone:2E7) or 0.5 ug Isotype Control. Cells were not fixed.
1X10^6 mouse splenocytes were surface co-stained with CoraLite® Plus 647 Anti-Mouse CD3 (17A2) and 0.5 ug CoraLite® Plus 555 Anti-Mouse CD103 (CL555-65047, Clone:2E7) or 0.5 ug Isotype Control. Cells were not fixed.
1x10^6 mouse splenocytes were surface stained with 0.4 ug CoraLite® Plus 647 Anti-Mouse CD103 (CL647-65047, Clone:2E7) or 0.4 ug Isotype Control, and 0.4 ug CoraLite® Plus 488 Anti-Mouse CD3 (17A2) (CL488-65077, Clone: 17A2). Cells were not fixed.
1X10^6 mouse splenocytes were surface co-stained with FITC Anti-Mouse CD3 and 0.5 ug CoraLite® Plus 750 Anti-Mouse CD103 (CL750-65047, Clone: 2E7) or 0.5 ug Isotype Control. Cells were not fixed.
1X10^6 mouse splenocytes were surface co-stained with FITC Anti-Mouse CD3 and 0.5 ug CoraLite®594 Anti-Mouse CD103 (CL594-65047, Clone: 2E7) or 0.5 ug Isotype Control. Cells were not fixed.
1X10^6 C57BL/6 mouse splenocytes were surface stained with APC-Anti-Mouse CD3 (APC-65077, Clone: 17A2) and 1.00 ug FITC Anti-Mouse CD103 (FITC-65047, Clone: 2E7). Cells were not fixed.
1X10^6 C57BL/6 mouse splenocytes were surface stained with APC-Anti-Mouse CD3 (APC-65077, Clone: 17A2) and 1.00 ug FITC-Armenian Hamster IgG isotype control antibody. Cells were not fixed.
